Tissue pharmacokinetics of cefazolin in patients with lower limb infections. - Wikidata - awgldk - TriplyDB

Tissue pharmacokinetics of cefazolin in patients with lower limb infections.

Tissue pharmacokinetics of cefazolin in patients with lower limb infections.

http://www.wikidata.org/entity/Q37263523

about

Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy.Population Pharmacokinetics of Cefazolin in Serum and Tissue for Patients with Complicated Skin and Soft Tissue Infections (cSSTI).Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass to optimize dosing regimens for children undergoing cardiac surgery.Population Pharmacokinetics of Cefazolin in Serum and Adipose Tissue From Overweight and Obese Women Undergoing Cesarean Delivery.Pharmacokinetics and Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients with Lower Limb Infections and Healthy Adult Volunteers.Pharmacokinetics of Cefuroxime in Synovial Fluid.Comparative Assessment of Tedizolid Pharmacokinetics and Tissue Penetration between Diabetic Patients with Wound Infections and Healthy Volunteers via In Vivo Microdialysis.

P2860

Q33784516-C36F32A1-8518-4200-8185-7106A8812B34 Q34726196-C6001D79-E126-42E3-AEAC-A00247250A81 Q39080543-89EE95C4-4B43-46E1-AA33-294A1C190D70 Q39124270-10472C12-5809-4592-AA00-C5A000B4ABA3 Q40052714-ACC27CCC-0AEF-45D3-89F1-656B12FADEFA Q47265801-CA90275A-7781-44BD-A267-C86D154A96E7 Q47647024-6DFFFDE3-1301-434A-98F7-AE37AD4C7A60

P2860

Tissue pharmacokinetics of cefazolin in patients with lower limb infections.

http://www.wikidata.org/entity/Q37263523

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tissue pharmacokinetics of cefazolin in patients with lower limb infections.

@en

Tissue pharmacokinetics of cefazolin in patients with lower limb infections.

@nl

type

label

Tissue pharmacokinetics of cefazolin in patients with lower limb infections.

@en

Tissue pharmacokinetics of cefazolin in patients with lower limb infections.

@nl

prefLabel

Tissue pharmacokinetics of cefazolin in patients with lower limb infections.

@en

Tissue pharmacokinetics of cefazolin in patients with lower limb infections.

@nl

P1433

Q37263523-015629C8-9520-4BA0-9690-ABDC8D312BE7

P1476

Q37263523-C8FC5A17-6E55-48E1-BD6B-73D69FC5A118

P2093

Q37263523-0000C45B-0CBA-4C0E-BBF6-071C7982161A

Q37263523-908398B2-021B-4081-AB1F-2C04C069DC37

Q37263523-CEEE3EB8-C6D7-4B45-8B84-15614932EC8E

Q37263523-CF15A772-9AB3-42BE-AEC5-38F24CE807CF

Q37263523-D9A0FED8-BE4B-4024-9D35-EFC738C07C32

P2860

Q37263523-18297242-A845-4807-B374-D98358B6609D

Q37263523-1BE00AD9-3873-42ED-984C-D6CA986A994D

Q37263523-1F4FA41B-736F-4E8F-9E5D-9BD94988762F

Q37263523-645E4886-0A85-42E8-8F4E-85740708832E

Q37263523-65C4D756-E8F8-4E10-9462-2E1752E59BDC

Q37263523-67F74F9B-05BA-4532-B682-0D9578BAC629

Q37263523-6846FAFB-7A82-4E44-8E84-7D18D4AFFB23

Q37263523-6A3B6D2D-615A-488F-9947-D0AB1A430F7C

Q37263523-6F6E0D1F-EC78-442A-9D4D-C997EA1FDF71

Q37263523-782F2A7F-62EA-4692-B19D-164FB617A98E

P304

Q37263523-54FC763A-15A0-4EA5-A5F9-C938E57FAE72

P31

Q37263523-18D55D72-6C5B-4B2B-A353-6435F45F5408

P356

Q37263523-9C3748B1-6BCE-4074-AB44-BAB7B80966B3

P407

Q37263523-2A72C0D2-ED3F-433F-9E05-EED744DFB5E8

P433

Q37263523-4AF99C6B-8D65-4AAC-B085-CC668C66E2E9

P478

Q37263523-9E546E68-3B7A-487B-BE2C-133B741D8330

P577

Q37263523-D27835A6-D53F-4610-AED9-02F40A06F25E

P698

Q37263523-5F2C2E67-AB65-47F2-887E-4B6F0B1029F8

P932

Q37263523-A3391EC3-2D91-4D9C-A423-4A6F12165C99

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Tissue pharmacokinetics of cefazolin in patients with lower limb infections.

@en

P2093

Amira A Bhalodi

http://www.w3.org/2001/XMLSchema#string

Ashley Shepard

http://www.w3.org/2001/XMLSchema#string

David P Nicolau

http://www.w3.org/2001/XMLSchema#string

James Nugent

http://www.w3.org/2001/XMLSchema#string

Seth T Housman

http://www.w3.org/2001/XMLSchema#string

P2860

The pharmacokinetics of cefazolin in patients undergoing elective & semi-elective abdominal aortic aneurysm open repair surgery.

Methodological issues in microdialysis sampling for pharmacokinetic studies.

Microdialysis in peripheral tissues.

Tissue penetration and pharmacokinetics of tigecycline in diabetic patients with chronic wound infections described by using in vivo microdialysis.

Efficacy of human simulated exposures of ceftaroline administered at 600 milligrams every 12 hours against phenotypically diverse Staphylococcus aureus isolates

Plasma and tissue pharmacokinetics of cefazolin in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgery.

Comparative penetration of cefonicid and cefazolin into the atrial appendage and pericardial fluid of patients undergoing open-heart surgery.

Pharmacokinetics and pulmonary disposition of tedizolid and linezolid in a murine pneumonia model under variable conditions.

Protein binding of cefazolin is saturable in vivo both between and within patients

Microdialysis: current applications in clinical pharmacokinetic studies and its potential role in the future.

P304

5679-5683

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01348-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24041887

http://www.w3.org/2001/XMLSchema#string

P932

3811311

http://www.w3.org/2001/XMLSchema#string